title: The second revision of the dopamine theory of schizophrenia: implications for treatment and drug development.
authors.affiliation: Neurosciences Therapeutic Area, New Medicines UCB Pharma, S.A., Baine-l'Alleud, Belgium. ml393@columbia.edu
authors.forename: Marc
authors.initials: M
authors.lastname: Laruelle
mesh_terms: D004298:Dopamine / Q000096:biosynthesis*; D005260:Female; D006801:Humans; D008297:Male; D017729:Presynaptic Terminals / Q000000981:diagnostic imaging*; D011618:Psychotic Disorders / Q000000981:diagnostic imaging*; D011877:Radionuclide Imaging
chemical_list: D004298:Dopamine